Tango Therapeutics, Inc. Earnings Per Share (Basic)
Tango Therapeutics, Inc. (TNGX) reported Earnings Per Share (Basic) of -$0.37 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Tango Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.37.
- Tango Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.32.
- Tango Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $0.14.
- Tango Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.35.
- Tango Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$0.87.
- Tango Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$1.19.
- Tango Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$1.08.
- Tango Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$1.23.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.37 10-Q · filed 2026-08-11 | -$0.68 10-Q · filed 2026-08-11 | ||
| 2026-03-31 | -$0.32 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | -$0.87 10-K · filed 2026-03-05 | |||
| 2025-09-30 | $0.14 10-Q · filed 2025-11-04 | -$0.57 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | -$0.35 10-Q · filed 2026-08-11 | -$0.71 10-Q · filed 2026-08-11 | ||
| 2025-03-31 | -$0.36 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$1.19 10-K · filed 2026-03-05 | |||
| 2024-09-30 | -$0.27 10-Q · filed 2025-11-04 | -$0.85 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | -$0.24 10-Q · filed 2025-08-05 | -$0.58 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | -$0.35 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$1.08 10-K · filed 2026-03-05 | |||
| 2023-09-30 | -$0.23 10-Q · filed 2024-11-06 | -$0.78 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | -$0.23 10-Q · filed 2024-08-07 | -$0.55 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$0.32 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$1.23 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$0.33 10-Q · filed 2023-11-08 | -$0.90 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | -$0.28 10-Q · filed 2023-08-07 | -$0.57 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | -$0.29 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$0.94 10-K · filed 2023-03-27 | |||
| 2021-09-30 | -$0.28 10-Q · filed 2022-11-10 | -$0.68 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$0.09 10-Q · filed 2022-08-10 | -$0.37 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |